Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Jacobs

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Oncotarget|May 10, 2014
Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanomaPowrnima Joshi, Barbara Jacobs, Adeeb Derakhshan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Cancer Research|June 18, 2002
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cellsElisabetta Padovan, Luigi Terracciano, Ulrich Certa, et al.
Oncotarget|December 29, 2011
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsTaolin Yi, Paul Elson, Masato Mitsuhashi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2Douglas W Leaman, Mamta Chawla-Sarkar, Barbara Jacobs, et al.
Plos One|July 19, 2017
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupusHarald Leiss, Wilhelm Salzberger, Barbara Jacobs, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Oncotarget|May 10, 2014
Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanomaPowrnima Joshi, Barbara Jacobs, Adeeb Derakhshan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Cancer Research|June 18, 2002
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cellsElisabetta Padovan, Luigi Terracciano, Ulrich Certa, et al.
Oncotarget|December 29, 2011
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsTaolin Yi, Paul Elson, Masato Mitsuhashi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2Douglas W Leaman, Mamta Chawla-Sarkar, Barbara Jacobs, et al.
Plos One|July 19, 2017
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupusHarald Leiss, Wilhelm Salzberger, Barbara Jacobs, et al.
Pageof 2